IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Microsoft has begun canceling leases for a substantial amount of datacenter capacity in the U.S., TD Cowen said in a report.

Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...

AllianceBernstein (NYSE:AB) was downgraded at TD Cowen after Equitable Holdings (NYSE:EQH) announced a tender offer for up to ...

TD Cowen analyst Joshua Buchalter had high praise for Nvidia following an earnings report that he said was "as straightforward as they come." Nvidia didn't deliver a beat-and-raise performance by the ...

In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Keros Therapeutics (KROS – Research Report). The ...

TD Cowen upgraded shares of Rocket Lab USA (NASDAQ:RKLB – Free Report) to a strong-buy rating in a research report sent to ...

TD Cowen analyst William Katz maintained a Buy rating on Apollo Global Management (APO – Research Report) today and set a price target of ...

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

The Washington-based software giant has canceled leases in the US totaling “a couple of hundred megawatts,” or about two huge data centers, according to a report from TD Cowen analysts ...